Lv4
578 积分 2024-05-13 加入
Effective preclinical activity of datopotamab deruxtecan (Dato-DXd), an ADC targeting trophoblast cell-surface antigen 2 (TROP2), against primary cervical carcinoma cell lines and xenografts
4个月前
已完结
The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor
8个月前
已完结
Targeting ATR in patients with cancer
8个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
8个月前
已完结
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy
8个月前
已完结
Design, classification, and adverse effects of NSAIDs: A review on recent advancements
8个月前
已完结
Chemically Modified Platforms for Better RNA Therapeutics
8个月前
已完结
Advances in structural-guided modifications of siRNA
8个月前
已完结
皖公网安备34019202002308
